[A new trend in psychopharmacology: designed psychopharmaceuticals with fewer adverse effects as a result of development of molecular biology?].
Wilhelmson
B
B
D000818:Animals; D015195:Drug Design; D006801:Humans; D008967:Molecular Biology; D011600:Psychopharmacology / Q000639:trends*; D011619:Psychotropic Drugs / Q000378:metabolism / Q000627:therapeutic use; D017981:Receptors, Neurotransmitter / Q000378:metabolism; D012106:Research
D011619:Psychotropic Drugs; D017981:Receptors, Neurotransmitter
"Vässade" psykofarmaka med mindre bieffekter i molekylärbiologins kölvatten?